Free Trial
→ Why Some AI Stocks Already Surged Over 300 Percent (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACH
Accendra Health
$0.28
-10.0%		$1.07
$0.28
▼
$5.60
$21.82M1.571.14 million shs2.49 million shs
DocGo Inc. stock logo
DCGO
DocGo
$0.29
-5.9%		$0.43
$0.29
▼
$1.65
$28.39M0.97859,760 shs553,035 shs
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$0.34
-8.0%		$0.44
$0.16
▼
$2.75
$7.40M1.988.51 million shs256,337 shs
RYOJ stock logo
RYOJ
RYOJ
$2.89
+4.9%		$4.30
$1.56
▼
$11.43
$33.32M4.54405,191 shs842 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACH
Accendra Health
-17.10%-30.11%-69.78%-91.07%+32,339,900.00%
DocGo Inc. stock logo
DCGO
DocGo
-8.63%-15.72%-13.40%-54.11%-75.98%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
-3.08%-17.42%-7.75%-0.80%-85.31%
RYOJ stock logo
RYOJ
RYOJ
-11.94%0.00%-40.86%-37.50%+274,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACH
Accendra Health
$0.28
-10.0%		$1.07
$0.28
▼
$5.60
$21.82M1.571.14 million shs2.49 million shs
DocGo Inc. stock logo
DCGO
DocGo
$0.29
-5.9%		$0.43
$0.29
▼
$1.65
$28.39M0.97859,760 shs553,035 shs
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$0.34
-8.0%		$0.44
$0.16
▼
$2.75
$7.40M1.988.51 million shs256,337 shs
RYOJ stock logo
RYOJ
RYOJ
$2.89
+4.9%		$4.30
$1.56
▼
$11.43
$33.32M4.54405,191 shs842 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACH
Accendra Health
-17.10%-30.11%-69.78%-91.07%+32,339,900.00%
DocGo Inc. stock logo
DCGO
DocGo
-8.63%-15.72%-13.40%-54.11%-75.98%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
-3.08%-17.42%-7.75%-0.80%-85.31%
RYOJ stock logo
RYOJ
RYOJ
-11.94%0.00%-40.86%-37.50%+274,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ACH
Accendra Health
1.60
Reduce$1.50428.73% Upside
DocGo Inc. stock logo
DCGO
DocGo
2.33
Hold$2.38727.53% Upside
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
1.00
SellN/AN/A
RYOJ stock logo
RYOJ
RYOJ
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest MGRX, DCGO, ACH, and RYOJ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/5/2026
ACH
Accendra Health
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeHold ➝ Strong Sell
9/30/2026
DocGo Inc. stock logo
DCGO
DocGo
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy
9/21/2026
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
9/14/2026
DocGo Inc. stock logo
DCGO
DocGo
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
9/1/2026
RYOJ stock logo
RYOJ
RYOJ
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (D-) ➝ Sell (D)
8/18/2026
DocGo Inc. stock logo
DCGO
DocGo
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingHold$1.00
8/18/2026
DocGo Inc. stock logo
DCGO
DocGo
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$3.00
8/13/2026
ACH
Accendra Health
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetNeutral$4.50 ➝ $1.50
8/11/2026
ACH
Accendra Health
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price TargetOutperform ➝ Neutral$1.50
8/11/2026
ACH
Accendra Health
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeOutperform ➝ Neutral$1.50
8/10/2026
ACH
Accendra Health
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeBuy ➝ Neutral$4.50 ➝ $1.50
(Data available from 10/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ACH
Accendra Health
$2.73B0.01$2.84 per share0.10($5.96) per share-0.05
DocGo Inc. stock logo
DCGO
DocGo
$322.20M0.09$0.05 per share6.03$1.28 per share0.22
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$460K16.04N/AN/A$0.93 per share0.37
RYOJ stock logo
RYOJ
RYOJ
$9.34M3.57$0.05 per share57.03$0.54 per share5.34
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ACH
Accendra Health
-$1.10B-$3.91N/A3.15N/A-11.41%-4.02%0.70%N/A
DocGo Inc. stock logo
DCGO
DocGo
-$182.40M-$1.96N/AN/AN/A-65.29%-40.42%-24.81%11/9/2026 (Estimated)
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
-$20.64M-$1.01N/AN/AN/A-4,794.60%-96.39%-89.60%N/A
RYOJ stock logo
RYOJ
RYOJ
$120KN/AN/AN/AN/AN/AN/AN/AN/A

Latest MGRX, DCGO, ACH, and RYOJ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
DocGo Inc. stock logo
DCGO
DocGo
-$0.1075N/AN/AN/A$77.25 millionN/A
8/17/2026Q2 2026
DocGo Inc. stock logo
DCGO
DocGo
-$0.0975-$0.16-$0.0625-$0.16$75.35 million$73.42 million
8/13/2026Q2 2026
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/A-$0.09N/A-$0.09N/A$0.08 million
8/10/2026Q2 2026
ACH
Accendra Health
-$0.13-$0.19-$0.06-$1.16N/A$613.23 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ACH
Accendra Health
N/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
N/AN/AN/AN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/AN/AN/AN/AN/A
RYOJ stock logo
RYOJ
RYOJ
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ACH
Accendra Health
N/A
0.41
0.30
DocGo Inc. stock logo
DCGO
DocGo
N/A
1.66
1.66
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/A
0.18
0.18
RYOJ stock logo
RYOJ
RYOJ
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ACH
Accendra Health
N/A
DocGo Inc. stock logo
DCGO
DocGo
56.44%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
56.72%
RYOJ stock logo
RYOJ
RYOJ
N/A

Insider Ownership

CompanyInsider Ownership
ACH
Accendra Health
2.29%
DocGo Inc. stock logo
DCGO
DocGo
5.10%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
16.00%
RYOJ stock logo
RYOJ
RYOJ
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ACH
Accendra Health
6,50076.90 million75.14 millionN/A
DocGo Inc. stock logo
DCGO
DocGo
3,56898.93 million93.88 millionOptionable
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
321.57 million18.12 millionNot Optionable
RYOJ stock logo
RYOJ
RYOJ
31311.55 millionN/AN/A

Recent News About These Companies

rYojbaba Rings the Nasdaq Stock Market Opening Bell, Celebrating Its Mission to “Fight Poverty” on the Global Stage
May 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/28/3303252/0/en/ryojbaba-rings-the-nasdaq-stock-market-opening-bell-celebrating-its-mission-to-fight-poverty-on-the-global-stage.html
Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
May 26, 2026  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/26/05/52770440/why-joyy-shares-are-trading-higher-by-12-here-are-20-stocks-moving-premarket
Lobbying Update: $250,000 of ACCENTURE FEDERAL SERVICES LLC lobbying was just disclosed
April 16, 2026  |  quiverquant.comQ
rYojbaba Investor News: Rosen Law Firm Encourages rYojbaba Co., Ltd. Investors to Inquire About Securities Class Action Investigation – RYOJ
April 16, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260416469369/en/ryojbaba-investor-news-rosen-law-firm-encourages-ryojbaba-co.-ltd.-investors-to-inquire-about-securities-class-action-investigation-%e2%80%93-ryoj/
Rosen Law Firm Encourages rYojbaba Co., Ltd. Investors to Inquire About Securities Class Action Investigation – RYOJ
April 15, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260415278470/en/rosen-law-firm-encourages-ryojbaba-co.-ltd.-investors-to-inquire-about-securities-class-action-investigation-%e2%80%93-ryoj/
Accenture Stock (ACN) Opinions on Quarterly Earnings
April 11, 2026  |  quiverquant.comQ
Accenture shares rise 3.3% after Q2 results show record bookings and higher full-year outlook
March 19, 2026  |  quiverquant.comQ
ACCENTURE ($ACN) Releases Q2 2026 Earnings
March 19, 2026  |  quiverquant.comQ
$ACN stock is down 3% today. Here's what we see in our data.
March 9, 2026  |  quiverquant.comQ
Accenture shares jump as new AI partnership adds momentum after recent selloff
February 26, 2026  |  quiverquant.comQ
rYojbaba Announces Participation in the Guardian Girls Aikido Project in Los Angeles, CA
February 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/23/3242640/0/en/ryojbaba-announces-participation-in-the-guardian-girls-aikido-project-in-los-angeles-ca.html
VTI is down 0.1% today, on ACN stock price movement
February 19, 2026  |  quiverquant.comQ
Accenture (ACN) slides as investors weigh aggressive internal AI adoption push
February 19, 2026  |  quiverquant.comQ
$ACN stock is down 5% today. Here's what we see in our data.
February 11, 2026  |  quiverquant.comQ
Insider Sale: Chair and CEO of $ACN Sells 1,843 Shares
February 10, 2026  |  quiverquant.comQ
VOO is down 0.3% today, on ACN stock price movement
February 3, 2026  |  quiverquant.comQ
Insider Sale: Chief Leadership & HR Officer of $ACN Sells 514 Shares
January 27, 2026  |  quiverquant.comQ
$ACN stock is down 4% today. Here's what we see in our data.
January 20, 2026  |  quiverquant.comQ
Accenture Stock (ACN) Opinions on AI Revenue Surge and Digital Identity Partnership
January 17, 2026  |  quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Close-up view of a quantum computing processor with copper wiring and a blue silicon chip.
Breaking Down the Impact of the CHIPS Funding Deal for Quantum Firms
By Nathan Reiff | September 15, 2026
Digital screen displays a red candlestick stock chart trending downward, illustrating a declining market against a city skyline.
3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
By Dan Schmidt | October 11, 2026
An upward-trending chart arrow is overlaid on a cornfield with grain silos at sunset, symbolizing agricultural market growth.
3 Surging Stocks That Don’t Need the AI Boom to Keep Winning
By Nathan Reiff | September 21, 2026
Computer monitor on a desk displaying an equity research dashboard with analyst ratings, price targets, and consensus price target charts.
Analysts See Double-Digit Upside for These 3 Stocks
By Ryan Hasson | September 17, 2026
Tesla vehicle on a road at dusk, front-facing, with an illuminated red Tesla logo on the hood.
Tesla’s Delivery Warning Barely Moved the Stock—Here’s What Investors Care About
By Sam Quirke | September 22, 2026

Accendra Health NYSE:ACH

$0.28 -0.03 (-9.97%)
As of 01:23 PM Eastern

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

DocGo stock logo

DocGo NASDAQ:DCGO

$0.29 -0.02 (-5.93%)
As of 01:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Mangoceuticals stock logo

Mangoceuticals NASDAQ:MGRX

$0.34 -0.03 (-7.97%)
As of 01:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

RYOJ stock logo

RYOJ NASDAQ:RYOJ

$2.88 +0.14 (+4.91%)
As of 01:43 PM Eastern
This is a fair market value price provided by Massive. Learn more.

rYojbaba Co., Ltd. operates a labor consulting and health services business. The labor consulting business provides strategic consulting services. It also operates osteopathic clinics and beauty salons within its health services business. rYojbaba Co., Ltd. is based in FUKUOKA, Japan.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas